Brief: BB Biotech Q3 Net Gain Up At CHF 242 Mln
Oct 19 (Reuters) - BB Biotech AG BION.S :
* DGAP-NEWS: BB BIOTECH AG: INVESTORS SHOWED RENEWED INTEREST IN BIOTECH STOCKS DURING THE
THIRD
QUARTER
* Q3 NET GAIN WAS CHF 242 MN, COMPARED TO CHF 365 MN FOR SAME PERIOD IN 2017
* MOMENTUM FOR BB BIOTECH'S PORTFOLIO EXPECTED TO REMAIN HIGH FOR LAST QUARTER OF 2018 AND
WELL
INTO 2019
Source text for Eikon: ID:nEQ7zDSsca
Further company coverage: BION.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM